|
STOCKHOLDERS' DEFICIT (Details 1) (USD $)
|
9 Months Ended |
|---|---|
|
Sep. 30, 2014
|
|
| Warrants outstanding at end of period | 245,000 |
|
Warrant $3.75 [Member]
|
|
| Warrant exercise price | $ 3.75 |
| Warrants outstanding at end of period | 240,000 |
| Weighted Average Remaining Contractual Life | 3 months 22 days |
| Number exercisable at end of period | 240,000 |
| Weighted Average Exercise Price | $ 3.75 |
|
Warrant $4.50 [Member]
|
|
| Warrant exercise price | $ 4.50 |
| Warrants outstanding at end of period | 5,000 |
| Weighted Average Remaining Contractual Life | 2 years 7 months 9 days |
| Number exercisable at end of period | 5,000 |
| Weighted Average Exercise Price | $ 4.50 |
|
Warrant Total [Member]
|
|
| Warrant exercise price | $ 3.75 |
| Warrants outstanding at end of period | 245,000 |
| Weighted Average Remaining Contractual Life | 1 year 4 months 9 days |
| Number exercisable at end of period | 245,000 |
| Weighted Average Exercise Price | $ 3.75 |
| X | ||||||||||
|
- Definition
Exercise price of the warrants. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Per share weighted average intrinsic value of equity-based compensation awards vested. Excludes stock and unit options. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|